Evidence map›Paper›PMID 42894725›Full record

ArticleCureus2026

When Appearances Deceive: A Silent Somatotroph Macroadenoma Presenting With Acromegaloid Features and Paradoxically Low Insulin-Like Growth Factor-1.

Emily M Mayar, Sing Y Sim

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily M MayarEndocrinology, University Hospitals Sussex NHS Foundation Trust, Brighton, GBR.
Sing Y SimEndocrinology, University Hospitals Sussex NHS Foundation Trust, Brighton, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silent somatotroph adenomas are uncommon pituitary neuroendocrine tumours (PitNETs) of the PIT1 lineage that express growth hormone (GH) immunohistochemically but without biochemical evidence of acromegaly. We report the case of a 32-year-old male patient referred with recurrent epistaxis, headache, right-sided diplopia, and third cranial nerve palsy. Clinical examination revealed acromegaloid features including frontal bossing, spade-like hands, and coarse facies, which were strongly suggestive of longstanding GH excess. However, preoperative insulin-like growth factor-1 (IGF-1) was paradoxically low at 13.1 nmol/L (reference range 15.5-33.1 nmol/L), creating a striking clinical-biochemical discordance. MRI demonstrated a giant sellar and suprasellar mass with chiasmal compression, right cavernous sinus invasion, and extension into the paranasal sinuses. The patient underwent endoscopic transsphenoidal resection. Neuropathology confirmed a densely granulated PIT1-lineage somatotroph adenoma with scattered GH positivity, diffuse Pit-1 staining, and a Ki-67 index below 2%. This case highlights the diagnostic challenge posed by silent somatotroph adenomas, underscores the limitations of biochemical assessment alone, and reinforces the essential role of histopathology and immunohistochemistry in establishing a definitive diagnosis. Long-term endocrine and neurosurgical surveillance is strongly recommended given the potential for phenotypic transformation to a functioning acromegaly syndrome.

Indexed as

acromegaloid featuresinsulin-like growth factor-1 (igf-1)pituitary neuroendocrine tumoursilent somatotroph adenomastalk effecttranssphenoidal surgery

Identifiers

PMID42894725
PMCPMC13676777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.